Myopia Control With Novel Eye Drops

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 26, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

October 30, 2022

Conditions
Myopia
Interventions
DRUG

BHVI1 eye drops

Including 35 children enrolled to receive BHVI1 eye-drops once nightly

DRUG

BHVI2 eye drops

Including 35 children enrolled to receive BHVI2 eye-drops once nightly

DRUG

BHVI3 eye drops

Including 35 children enrolled to receive BHVI3, combination of BHVI1 and BHVI2, eye-drops once nightly

Trial Locations (1)

700000

Department of Ophthalmology - An Sinh Hospital, Ho Chi Minh City

All Listed Sponsors
collaborator

Brien Holden Vision Institute

OTHER

lead

Hai Yen Eye Care

INDUSTRY

NCT04301323 - Myopia Control With Novel Eye Drops | Biotech Hunter | Biotech Hunter